Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Gilead Sciences, Inc.
Scientific Title
A Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Subjects With Metastatic or Locally Advanced Unresectable Urothelial Cancer (TROPiCS-04)